Gainers
-
GlycoMimetics Inc (NASDAQ: GLYC) shares rose 35
percent to $7.25 in pre-market trading as the company reported that GMI-1271 has received the FDA Breakthrough therapy
designation for adult relapsed/refractory acute myeloid leukemia.
-
Affimed NV (NASDAQ: AFMD) shares rose 22.2
percent to $2.75 in the pre-market trading session. Affimed reported that it will present immune cell engager data at the
American Society of Clinical Oncology Annual Meeting and EACR-AACR-SIC Special Conference.
-
CytRx Corporation (NASDAQ: CYTX) rose 19.1
percent to $0.540 in pre-market trading. CytRx will present global Phase 3 aldoxorubicin clinical data in patients with soft
tissue sarcomas at the 2017 ASCO Annual Meeting.
-
Syndax Pharmaceuticals Inc (NASDAQ: SNDX) shares
rose 10.5 percent to $15.00 in pre-market trading after surging 44.62 percent on Wednesday. Syndax issued results from Phase 2
ENCORE 601 trial of entinostat in combo with Merck's KEYTRUDA for the treatment of advanced melanoma.
-
xG Technology Inc (NASDAQ: XGTI) rose 9.7 percent
to $2.04 in pre-market trading after declining 7.92 percent on Wednesday.
-
Pandora Media Inc (NYSE: P) rose 8.7 percent to $9.71
in pre-market trading. Sirius XM Holdings Inc. (NASDAQ: SIRI) is in talks about bidding for Pandora, according to sources as reported
by the New York Post.
-
Incyte Corporation (NASDAQ: INCY) rose 7.9
percent to $130.00 in pre-market trading. Incyte disclosed that its IDO1 enzyme inhibitor in combo with Merck's anti-PD-1
therapy is 'well-tolerated and demonstrated durable clinical responses across multiple solid tumors'. The company also
announced that first data from combo of epacadostat with Bristol-Myers' opdivo showed that combo is 'well-tolerated and
demonstrates promising clinical outcomes in multiple advanced solid tumors.'
-
Shire PLC (ADR) (NASDAQ: SHPG) rose 7.3 percent
to $195.50 in pre-market trading after the company disclosed that its lanadelumab study met primary endpoint.
-
Janus Capital Group Inc (NYSE: JNS) rose 7.2 percent
to $14.85 in pre-market trading after declining 3.01 percent on Wednesday.
-
Childrens Place Inc (NASDAQ: PLCE) rose 6.6
percent to $119.00 in pre-market trading after the company posted upbeat quarterly profit.
-
Ralph Lauren Corp (NYSE: RL) shares rose 5.2 percent
to $76.50 in pre-market trading after the company posted upbeat quarterly profit.
-
L Brands Inc (NYSE: LB) rose 5 percent to $50.81 in
pre-market trading after the company reported upbeat earnings for its first quarter and raised its FY17 outlook.
Inventure Foods Inc (NASDAQ: SNAK) shares rose 5
percent to $4.26 in pre-market trading after dropping 2.17 percent on Wednesday.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
-
Petroleo Brasileiro SA Petrobras (ADR) (NYSE: PBR)
fell 15 percent to $8.75 in pre-market trading. Petrobras CEO said that the company will pay first dividend since 2014, if it
earns profit in 2017, Reuters reported.
-
Itau Unibanco Holding SA (ADR) (NYSE: ITUB) fell
14.7 percent to $10.69 in pre-market trading after dipping 3.28 percent on Wednesday.
-
Gerdau SA (ADR) (NYSE: GGB) fell 14.7 percent to
$2.72 in pre-market trading after declining 3.19 percent on Wednesday.
-
Banco Bradesco SA (ADR) (NYSE: BBD) shares fell 13.3
percent to $8.70 in the pre-market trading session after dropping 3.09 percent on Wednesday.
-
Workhorse Group Inc (NASDAQ: WKHS) fell 9.6
percent to $3.00 in pre-market trading after rising 4.73 percent on Wednesday.
-
Vale SA (ADR) (NYSE: VALE) fell 9.3 percent to
$7.75 in pre-market trading after dropping 2.62 percent on Wednesday.
-
ZTO Express (Cayman) Inc (ADR) (NYSE: ZTO) shares
fell 7.4 percent to $13.01 in pre-market trading. ZTO reported Q1 adjusted earnings of $0.10 per share on sales of $379.9
million. The company also named Hongqun Hu as COO.
-
Cisco Systems, Inc. (NASDAQ: CSCO) shares fell
7.2 percent to $31.40 in pre-market trading. Cisco reported better-than-expected earnings for its third quarter, but issued a
weak revenue forecast for the current quarter. Cisco also announced plans to cut an additional 1,100 jobs.
-
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX)
fell 6.5 percent to $5.20 in pre-market trading after dropping 4.30 percent on Wednesday.
-
Stratasys, Ltd. (NASDAQ: SSYS) fell 6.1 percent
to $26.10 in pre-market trading. Jefferies downgraded Stratasys from Buy to Hold.
-
BlackBerry Ltd (NASDAQ: BBRY) fell 5 percent to
$9.60 in pre-market trading after slipping 0.79 percent on Wednesday.
-
Melco Resorts & Entertainment Ltd(ADR) (NASDAQ: MLCO) fell around 4.1 percent to $20.39 in pre-market trading after dropping
6.26 percent on Wednesday.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.